{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:41:50Z","timestamp":1776184910233,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":5053,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1093\/annonc\/mdj059","type":"journal-article","created":{"date-parts":[[2005,11,30]],"date-time":"2005-11-30T02:57:50Z","timestamp":1133319470000},"page":"289-296","source":"Crossref","is-referenced-by-count":173,"title":["Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial"],"prefix":"10.1016","volume":"17","author":[{"given":"M.","family":"Karthaus","sequence":"first","affiliation":[]},{"given":"A.","family":"Kretzschmar","sequence":"additional","affiliation":[]},{"given":"H.","family":"Kr\u00f6ning","sequence":"additional","affiliation":[]},{"given":"M.","family":"Biakhov","sequence":"additional","affiliation":[]},{"given":"D.","family":"Irwin","sequence":"additional","affiliation":[]},{"given":"N.","family":"Marschner","sequence":"additional","affiliation":[]},{"given":"C.","family":"Slabber","sequence":"additional","affiliation":[]},{"given":"G.","family":"Fountzilas","sequence":"additional","affiliation":[]},{"given":"A.","family":"Garin","sequence":"additional","affiliation":[]},{"given":"N.G.F.","family":"Abecasis","sequence":"additional","affiliation":[]},{"given":"W.","family":"Baronius","sequence":"additional","affiliation":[]},{"given":"G.G.","family":"Steger","sequence":"additional","affiliation":[]},{"given":"T.","family":"S\u00fcdhoff","sequence":"additional","affiliation":[]},{"given":"C.","family":"Giorgetti","sequence":"additional","affiliation":[]},{"given":"P.","family":"Reichardt","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdj059_bb0010","first-page":"281","article-title":"Plegmasia alba dolens. In Trousseau A (ed.): Lectures on Clinical Medicine, delivered at the Hotel-Dieu, Paris. Cormack JR, trans. London: New Syndenham","author":"Trousseau","year":"1872","journal-title":"Society"},{"key":"10.1093\/annonc\/mdj059_bb0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0049-3848(01)00285-7","article-title":"Molecular basis for the relationship between thrombosis and cancer","volume":"102","author":"Rickles","year":"2001","journal-title":"Thromb Res"},{"key":"10.1093\/annonc\/mdj059_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-2007-994915","article-title":"The thrombophilic state induced by therapeutic agents in the cancer patient","volume":"25","author":"Lee","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1093\/annonc\/mdj059_bb0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2007-994916","article-title":"Thrombotic complications of central venous catheters in cancer patients","volume":"25","author":"Bona","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1093\/annonc\/mdj059_bb0030","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2003.08.008","article-title":"Venous thromboembolism associated with long-term use of central venous catheters in cancer patients","volume":"21","author":"Verso","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj059_bb0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2141.1998.00732.x","article-title":"Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies","volume":"101","author":"Boraks","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdj059_bb0040","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S1051-0443(07)61307-4","article-title":"Venous thrombosis associated with the placement of peripherally inserted central catheters","volume":"11","author":"Allen","year":"2000","journal-title":"J Vasc Interv Radiol"},{"key":"10.1093\/annonc\/mdj059_bb0045","first-page":"260","article-title":"Venous thrombosis and pulmonary embolism","volume":"187","author":"Diebold","year":"1991","journal-title":"A study of 5039 autopsies. Pathol Res Pract"},{"key":"10.1093\/annonc\/mdj059_bb0050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0720-048X(95)00633-2","article-title":"Central venous catheter-related thrombosis in clinically asymptomatic oncologic patients: a phlebographic study","volume":"20","author":"Balestreri","year":"1995","journal-title":"Eur J Radiol"},{"key":"10.1093\/annonc\/mdj059_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0038-1650254","article-title":"Upper extremity deep venous thrombosis in cancer patients with venous access devices\u2014prophylaxis with a low molecular weight heparin (Fragmin)","volume":"75","author":"Monreal","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1093\/annonc\/mdj059_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(97)00054-6","article-title":"Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter","volume":"86","author":"DeCicco","year":"1997","journal-title":"A prospective study. Thromb Res"},{"key":"10.1093\/annonc\/mdj059_bb0065","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-2044.1996.tb14972.x","article-title":"Filshie J. A review of 560 Hickman catheter insertions","volume":"51","author":"Ray","year":"1996","journal-title":"Anaesthesia"},{"key":"10.1093\/annonc\/mdj059_bb0070","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0959-8049(97)89012-0","article-title":"A prospect analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy","volume":"33","author":"Nightingale","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdj059_bb0075","first-page":"1635","article-title":"Subcutaneously implanted central venous access devices in cancer patients","volume":"79","author":"Schwarz","year":"1997","journal-title":"A prospective analysis. Cancer"},{"key":"10.1093\/annonc\/mdj059_bb0080","first-page":"423","article-title":"Very low doses of warfarin can prevent thrombosis in central venous catheters","volume":"112","author":"Bern","year":"1990","journal-title":"A randomized prospective trial. Ann Intern Med"},{"key":"10.1093\/annonc\/mdj059_bb0085","unstructured":"Karthaus M, Suedhoff T, Reichardt P et al. Frequency of central venous catheter (CVC)-related infections in cancer patients (CP) treated on a double-blind Phase III trial of dalteparin versus placebo for the prevention of catheter-related complications (CRC). Procceedings of the 42nd ICAAC, San Diego, CA, USA: American Society for Microbiology, 27-30 September 2002. Abstract K667."},{"key":"10.1093\/annonc\/mdj059_bb0090","first-page":"280","article-title":"Upper-extremity deep venous thrombosis and pulmonary embolism","volume":"99","author":"Monreal","year":"1991","journal-title":"A prospective study. Chest"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdj059_bb0095","first-page":"32","article-title":"Prevention of venous thromboembolism in cancer using low molecular-weight heparins","volume":"27","author":"Kakkar","year":"1997","journal-title":"Haemostasis"},{"key":"10.1093\/annonc\/mdj059_bb0100","first-page":"43","article-title":"Venous thromboembolism in malignancy and malignancy in venous thromboembolism","volume":"28","author":"Rickles","year":"1998","journal-title":"Haemostasis"},{"key":"10.1093\/annonc\/mdj059_bb0105","first-page":"2486","article-title":"In: Physicians' Desk Reference","author":"Fragmin\u00ae","year":"1999"},{"key":"10.1093\/annonc\/mdj059_bb0110","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1182\/blood-2002-09-2731","article-title":"PARKAA Investigators Central venous line-related thrombosis in children: association with central venous line location and insertion technique","volume":"101","author":"Male","year":"2003","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdj059_bb0115","first-page":"117","article-title":"Thrombosis and cancer","volume":"48","author":"Valente","year":"2000","journal-title":"Minerva Cardioangiol"},{"key":"10.1093\/annonc\/mdj059_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2007-994916","article-title":"Thrombotic complications of central venous catheters in cancer patients","volume":"25","author":"Bona","year":"1999","journal-title":"Semin Thromb Haemost"},{"key":"10.1093\/annonc\/mdj059_bb0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/clon.1999.9023","article-title":"The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer","volume":"11","author":"Johnson","year":"1999","journal-title":"Clin Oncol"},{"key":"10.1093\/annonc\/mdj059_bb0130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0950-3536(98)80089-9","article-title":"Venous thromboembolism and cancer","volume":"11","author":"Kakkar","year":"1998","journal-title":"Baillieres Clin Haematol"},{"key":"10.1093\/annonc\/mdj059_bb0135","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archinte.1988.00380020229035","article-title":"Cancer and deep venous thrombosis","volume":"148","author":"Monreal","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1093\/annonc\/mdj059_bb0140","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/annonc\/mdh049","article-title":"Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients","volume":"15","author":"Biffi","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdj059_bb0145","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1200\/JCO.2005.10.192","article-title":"A randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer","volume":"23","author":"Couban","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj059_bb0150","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2005.06.084","article-title":"Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients","volume":"23","author":"Verso","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3 Suppl","key":"10.1093\/annonc\/mdj059_bb0155","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdj059_bb0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1200\/JCO.1995.13.1.233","article-title":"Complications of indwelling venous access devices in cancer patients","volume":"13","author":"Eastridge","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj059_bb0165","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1051-0443(99)70066-7","article-title":"Long-term follow-up of upper extremity implanted venous access devices in oncology patients","volume":"10","author":"Lyon","year":"1999","journal-title":"J Vasc Interv Radiol"},{"key":"10.1093\/annonc\/mdj059_bb0170","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1992.10.12.1943","article-title":"A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients","volume":"10","author":"Mueller","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj059_bb0175","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/archinte.163.16.1913","article-title":"Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review","volume":"163","author":"Klerk","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1093\/annonc\/mdj059_bb0180","first-page":"599","article-title":"McHutchion E. A change in flushing protocols of central venous catheters","volume":"19","author":"Kelly","year":"1992","journal-title":"Oncol Nurs Forum"},{"key":"10.1093\/annonc\/mdj059_bb0185","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archinte.158.9.1005","article-title":"Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism","volume":"158","author":"White","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1093\/annonc\/mdj059_bb0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","article-title":"PROTEKT Study Group. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb Res"},{"key":"10.1093\/annonc\/mdj059_bb0195","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0049-3848(03)00059-8","article-title":"REVIVE Study Group. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb Res"},{"key":"10.1093\/annonc\/mdj059_bb0200","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archinte.162.15.1729","article-title":"Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study","volume":"162","author":"Meyer","year":"2002","journal-title":"Arch Intern Med"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419403785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419403785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/17\/2\/289\/392328\/mdj059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T07:37:14Z","timestamp":1624433834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419403785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0923753419403785"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdj059","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}